- Home
- ANVS vs FORA Comparison
ANVS vs FORA Comparison
Compare ANVS & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANVS
- FORA
- Stock Information
- Founded
- ANVS 2008
- FORA 2014
- Country
- ANVS United States
- FORA United States
- Employees
- ANVS N/A
- FORA N/A
- Industry
- ANVS Biotechnology: Pharmaceutical Preparations
- FORA Computer Software: Prepackaged Software
- Sector
- ANVS Health Care
- FORA Technology
- Exchange
- ANVS Nasdaq
- FORA Nasdaq
- Market Cap
- ANVS 44.6M
- FORA 66.1M
- IPO Year
- ANVS 2020
- FORA N/A
- Fundamental
- Price
- ANVS $2.86
- FORA $2.01
- Analyst Decision
- ANVS Strong Buy
- FORA Strong Buy
- Analyst Count
- ANVS 4
- FORA 1
- Target Price
- ANVS $18.00
- FORA $5.00
- AVG Volume (30 Days)
- ANVS 442.5K
- FORA 7.5K
- Earning Date
- ANVS 08-14-2025
- FORA 08-13-2025
- Dividend Yield
- ANVS N/A
- FORA N/A
- EPS Growth
- ANVS N/A
- FORA N/A
- EPS
- ANVS N/A
- FORA N/A
- Revenue
- ANVS N/A
- FORA $22,332,001.00
- Revenue This Year
- ANVS N/A
- FORA $46.25
- Revenue Next Year
- ANVS N/A
- FORA $11.30
- P/E Ratio
- ANVS N/A
- FORA N/A
- Revenue Growth
- ANVS N/A
- FORA 5.22
- 52 Week Low
- ANVS $1.11
- FORA $1.85
- 52 Week High
- ANVS $14.80
- FORA $4.03
- Technical
- Relative Strength Index (RSI)
- ANVS 57.81
- FORA 49.88
- Support Level
- ANVS $2.24
- FORA $1.96
- Resistance Level
- ANVS $2.97
- FORA $2.18
- Average True Range (ATR)
- ANVS 0.26
- FORA 0.09
- MACD
- ANVS 0.02
- FORA 0.00
- Stochastic Oscillator
- ANVS 65.58
- FORA 37.04
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.